Public Health

The global rollout of COVID-19 vaccines will be the largest, fastest and most challenging vaccination program in history. This could bring many problems. Some we will anticipate; some we won’t. One glaring problem that is quickly emerging is a major mismatch between vaccine supply and demand.

Almost a third of people globally have gained weight during pandemic, despite awareness of link between obesity and COVID-19 outcomes.

New Ipsos-World Economic Forum survey following the release of a vaccine in the U.S. and U.K finds intentions to get vaccinated up in both countries, but down in several others as many worry about side effects.

This has been a year of momentous change – real and anticipated. As we pause to reflect at the end of the year, we present some Ipsos research highlights you may have missed during the dizzying events of 2020.

In the third edition of Flair Russia, Ipsos experts share their vision of what the future may hold for us over the coming years and what signals of the future we can recognise today.

The success of a COVID-19 vaccine is one of the biggest challenges we face globally. This paper explores the opportunities and obstacles that lie ahead.

Our new 27-country survey finds rising levels of satisfaction and trust in health services as the world battles against the coronavirus pandemic. Waiting times and lack of staff are the main challenges perceived by the public.

Worldwide, more than 50 million people have contracted Covid-19. But the health cost to women goes far beyond the virus itself. AXA and Ipsos today reveal the results of a second study conducted among women on the impact of Covid-19.

Most adults across 15 countries don’t expect a vaccine to be available any sooner than mid-2021; only half would get vaccinated within three months of its availability.